IL10 rs1800870: What Your Genotype Means
The genetic variant rs1800870 is a single nucleotide polymorphism located in the promoter region of the IL10 gene, commonly referred to in medical literature as the -1082 (G/A) variant. This change alters the transcriptional efficiency of interleukin-10, a vital anti-inflammatory cytokine that orchestrates the resolution of immune responses. Scientific studies associate this variant with differences in baseline cytokine production, influencing predisposition to chronic inflammatory conditions and autoimmune disorders.
What each genotype means
Reduced IL-10 Production
You carry two copies of the A allele, which has been correlated in research with lower baseline transcriptional expression of the anti-inflammatory cytokine interleukin-10. Published studies show this low-expression profile may be associated with increased susceptibility to certain autoimmune or inflammatory conditions, although findings remain limited, mixed, and context-dependent across populations. These statistical associations reflect complex genetic and environmental influences rather than a diagnosis.
Carried by approximately 15% to 25% of individuals of European ancestry, but rare in East Asian populations where the A allele frequency is low.
Intermediate IL-10 Production
You carry one copy of the A allele and one copy of the G allele, which is typically linked to intermediate interleukin-10 expression levels compared to the homozygous genotypes. While some observational studies note modest shifts in immune regulation or inflammation-related disease susceptibility, evidence is limited and often conflicting across different clinical contexts and ancestries. This genotype represents a common balanced profile rather than a predictor of health outcomes.
Carried by roughly 45% to 50% of European populations and approximately 15% of East Asian populations.
Higher IL-10 Production
You carry two copies of the G allele, which experimental and observational studies traditionally correlate with higher transcriptional levels of the anti-inflammatory cytokine interleukin-10. Higher interleukin-10 expression may temper inflammatory responses, though some research suggests it could play varied roles in chronic viral clearance or immune modulation. Published clinical findings remain mixed, and this genetic finding does not diagnose any condition.
Carried by approximately 30% of European individuals and predominates in East Asian populations, where it is found in over 80% of individuals.
Understanding the IL10 -1082 Promoter Variant
The single nucleotide polymorphism rs1800870 is situated within the proximal promoter region of the interleukin 10 (IL10) gene, exactly 1,082 base pairs upstream of the transcription start site (-1082 G/A). In scientific literature, it is often studied alongside neighboring promoter variants such as -819 C/T (rs1800871) and -592 C/A (rs1800872). Because promoter regions act as docking platforms for transcription factors and cellular machinery, small variations here can alter how readily a gene is transcribed into messenger RNA. For rs1800870, the presence of either a guanine (G) or an adenine (A) nucleotide modulates the recruitment of nuclear transcription factors, directly impacting the transcriptional efficiency of the downstream cytokine gene.
Biological Role of Interleukin-10 in Immunity
The IL10 gene encodes interleukin-10, an essential anti-inflammatory cytokine primarily secreted by monocytes, macrophages, and regulatory T lymphocytes. In a balanced immune system, IL-10 serves as a master regulator, preventing tissue damage by dampening excessive inflammatory signaling, limiting antigen presentation, and suppressing the release of pro-inflammatory mediators like TNF-alpha and IL-6. Adequate production of IL-10 is critical for resolving inflammation after infections and preventing the immune system from attacking healthy host tissues. When genetic variants modulate IL-10 levels, the body's natural threshold for maintaining immune homeostasis and clearing pathogens can shift.
Evaluating Research and Disease Associations
Historically, molecular studies have identified the G allele at position -1082 as a higher-producing allele for IL-10, whereas the A allele has been linked to lower constitutive expression and lower circulating protein concentrations. Because IL-10 suppresses inflammation, individuals carrying the A allele (or the ATA promoter haplotype) have been investigated for increased susceptibility to chronic inflammatory and autoimmune diseases, such as inflammatory bowel disease, rheumatoid arthritis, and systemic lupus erythematosus. Conversely, higher IL-10 production associated with the G allele can sometimes hinder robust clearance of specific viral pathogens, such as HIV, HBV, and dengue. Despite extensive investigation, the clinical evidence remains classified as limited and mixed, as many candidate-gene associations show modest effect sizes and vary across study cohorts.
Translating Findings to Personal Health
Genetic results for rs1800870 describe statistical tendencies in cytokine expression across populations rather than definitive clinical diagnoses. Carrying an allele linked to lower or higher IL-10 production does not mean an individual is destined to develop an autoimmune disease or experience chronic systemic inflammation. Human immune responses are multifaceted polygenic traits influenced heavily by diet, physical activity, chronic stress, viral exposures, and gut microbiome composition. Consumers should view rs1800870 as one small piece of biological context. Genetic information should never be used to self-treat or alter prescribed medical regimens; any questions regarding immune health should be discussed directly with a qualified healthcare professional.
How common is this variant?
The minor allele frequency for rs1800870 varies significantly by ancestry, standing at approximately 0.45 in populations of European descent and roughly 0.08 in East Asian populations.
Frequently asked questions
What does the IL10 rs1800870 variant indicate about inflammation?
The rs1800870 variant is associated with differences in the production of interleukin-10, an anti-inflammatory protein. Individuals carrying the A allele generally produce lower levels of IL-10, which can slightly increase susceptibility to elevated systemic inflammation, whereas the G allele is linked to higher IL-10 production.
Does having the AA genotype mean I will develop an autoimmune disease?
No, having the AA genotype does not mean you will develop an autoimmune disorder. While studies show a modest statistical association with reduced anti-inflammatory cytokine output, autoimmune conditions are complex and depend on many other genes, environmental factors, and lifestyle triggers.
What is the difference between rs1800870 and the -1082 G/A notation?
They refer to the exact same genetic variant. The label rs1800870 is the standardized identifier used in genomic databases like dbSNP, while -1082 G/A is the classical nomenclature describing a guanine-to-adenine substitution 1,082 base pairs upstream in the promoter region of the IL10 gene.
Can diet or lifestyle offset the effects of the rs1800870 variant?
Yes, lifestyle choices strongly influence systemic inflammatory markers. Adopting an anti-inflammatory dietary pattern, engaging in regular moderate exercise, prioritizing sleep, and managing chronic stress can support immune regulation regardless of your specific IL10 genotype.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800870?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL10
Regulatory upstream noncoding variant in IL10 that influences anti-inflammatory cytokine production.
The IL-10 promoter -819C/T polymorphism modulates interleukin-10 expression, influencing inflammatory responses and autoimmune susceptibility.
The -592C/A variant in the promoter of IL-10 regulates transcription factor binding, impacting cytokine output and risk for inflammatory bowel disease.
Part of the extended IL-10 promoter haplotype influencing differential anti-inflammatory IL-10 cytokine output and susceptibility to graft-versus-host disease.
Functional promoter variant (-1082 A/G) influencing interleukin-10 expression levels and inflammatory disease susceptibility.
Functional regulatory promoter variant in IL10 associated with altered interleukin-10 expression and enhanced susceptibility to dust mite allergic sensitization.